secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0000055529-22-000020
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific Q2 sales up 39.8% to $54.6M; net loss narrows to $0.09/share from $1.11
--------------------------------------------------------------------------------

- Sales $54.6M (+39.8% YoY); pre-tax earnings $456k vs loss $2.9M; net loss $243k vs $3.1M.
- Diluted loss per share $0.09 vs $1.11; EBITDA $1.25M vs ($2.12M).
- Domestic segment sales $38.0M (+26.9%); international segment $16.6M (+82.2%).
- Backlog $157.8M (up from $139.7M YoY); cash $16.3M (vs $6.9M); no short-term debt.
- CEO says improvement despite legacy direct contracts; continuing shift to dealer partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552922000020/0000055529-22-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552922000020/kequ-20221207.htm
  HTML page:      https://secwatch.observer/filing/0000055529-22-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer